Literature DB >> 28497292

Cancer subtypes in aetiological research.

Lorenzo Richiardi1,2, Francesco Barone-Adesi3, Neil Pearce4,5.   

Abstract

Researchers often attempt to categorize tumors into more homogeneous subtypes to better predict prognosis or understand pathogenic mechanisms. In clinical research, typically the focus is on prognosis: the tumor subtypes are intended to be associated with specific responses to treatment and/or different clinical outcomes. In aetiological research, the focus is on identifying distinct pathogenic mechanisms, which may involve different risk factors. We used directed acyclic graphs to present a framework for considering potential biases arising in aetiological research of tumor subtypes, when there is incomplete correspondence between the identified subtypes and the underlying pathogenic mechanisms. We identified two main scenarios: (1) weak effect, when the tumor subtypes are identified through combinations of characteristics and some of these characteristics are affected by factors that are unrelated with the underlying pathogenic mechanisms; and (2) lack of causality, when the set of characteristics corresponds with a mechanism that is actually not a cause of the tumor of interest. Examples of the magnitude of bias that can be introduced in these situations are provided. Although categorization of tumors into homogenous subtypes may have important implications for aetiological research and identification of risk factors, the characteristics used to classify tumors into subtypes should be as close as possible to the actual pathogenic mechanisms to avoid interpretative biases. Whenever our knowledge of these mechanisms is limited, research into risk factors for tumor subtypes should first aim to causally link the characteristics to the pathogenic mechanisms.

Entities:  

Keywords:  Aetiological research; Bias; Cancer subtypes; Disease classification; Molecular characteristics

Mesh:

Year:  2017        PMID: 28497292     DOI: 10.1007/s10654-017-0253-z

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  32 in total

Review 1.  Asthma phenotypes: the evolution from clinical to molecular approaches.

Authors:  Sally E Wenzel
Journal:  Nat Med       Date:  2012-05-04       Impact factor: 53.440

2.  Cardiovascular precision medicine: hope or hype?

Authors:  Geoffrey S Pitt
Journal:  Eur Heart J       Date:  2015-06-14       Impact factor: 29.983

3.  The current deconstruction of paradoxes: one sign of the ongoing methodological "revolution".

Authors:  Miquel Porta; Paolo Vineis; Francisco Bolúmar
Journal:  Eur J Epidemiol       Date:  2015-07-12       Impact factor: 8.082

Review 4.  How many etiological subtypes of breast cancer: two, three, four, or more?

Authors:  William F Anderson; Philip S Rosenberg; Aleix Prat; Charles M Perou; Mark E Sherman
Journal:  J Natl Cancer Inst       Date:  2014-08-12       Impact factor: 13.506

5.  Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology.

Authors:  Antonella Muraro; Robert F Lemanske; Peter W Hellings; Cezmi A Akdis; Thomas Bieber; Thomas B Casale; Marek Jutel; Peck Y Ong; Lars K Poulsen; Peter Schmid-Grendelmeier; Hans-Uwe Simon; Sven F Seys; Ioana Agache
Journal:  J Allergy Clin Immunol       Date:  2016-05       Impact factor: 10.793

6.  The molecular basis of breast cancer pathological phenotypes.

Authors:  Yujing J Heng; Susan C Lester; Gary Mk Tse; Rachel E Factor; Kimberly H Allison; Laura C Collins; Yunn-Yi Chen; Kristin C Jensen; Nicole B Johnson; Jong Cheol Jeong; Rahi Punjabi; Sandra J Shin; Kamaljeet Singh; Gregor Krings; David A Eberhard; Puay Hoon Tan; Konstanty Korski; Frederic M Waldman; David A Gutman; Melinda Sanders; Jorge S Reis-Filho; Sydney R Flanagan; Deena Ma Gendoo; Gregory M Chen; Benjamin Haibe-Kains; Giovanni Ciriello; Katherine A Hoadley; Charles M Perou; Andrew H Beck
Journal:  J Pathol       Date:  2016-12-29       Impact factor: 7.996

7.  Asthma and wheezing in the first six years of life. The Group Health Medical Associates.

Authors:  F D Martinez; A L Wright; L M Taussig; C J Holberg; M Halonen; W J Morgan
Journal:  N Engl J Med       Date:  1995-01-19       Impact factor: 91.245

8.  Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies.

Authors:  Fiona M Blows; Kristy E Driver; Marjanka K Schmidt; Annegien Broeks; Flora E van Leeuwen; Jelle Wesseling; Maggie C Cheang; Karen Gelmon; Torsten O Nielsen; Carl Blomqvist; Päivi Heikkilä; Tuomas Heikkinen; Heli Nevanlinna; Lars A Akslen; Louis R Bégin; William D Foulkes; Fergus J Couch; Xianshu Wang; Vicky Cafourek; Janet E Olson; Laura Baglietto; Graham G Giles; Gianluca Severi; Catriona A McLean; Melissa C Southey; Emad Rakha; Andrew R Green; Ian O Ellis; Mark E Sherman; Jolanta Lissowska; William F Anderson; Angela Cox; Simon S Cross; Malcolm W R Reed; Elena Provenzano; Sarah-Jane Dawson; Alison M Dunning; Manjeet Humphreys; Douglas F Easton; Montserrat García-Closas; Carlos Caldas; Paul D Pharoah; David Huntsman
Journal:  PLoS Med       Date:  2010-05-25       Impact factor: 11.069

9.  Molecular pathological epidemiology gives clues to paradoxical findings.

Authors:  Reiko Nishihara; Tyler J VanderWeele; Kenji Shibuya; Murray A Mittleman; Molin Wang; Alison E Field; Edward Giovannucci; Paul Lochhead; Shuji Ogino
Journal:  Eur J Epidemiol       Date:  2015-10-07       Impact factor: 8.082

10.  Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Lindsay M Morton; Susan L Slager; James R Cerhan; Sophia S Wang; Claire M Vajdic; Christine F Skibola; Paige M Bracci; Silvia de Sanjosé; Karin E Smedby; Brian C H Chiu; Yawei Zhang; Sam M Mbulaiteye; Alain Monnereau; Jennifer J Turner; Jacqueline Clavel; Hans-Olov Adami; Ellen T Chang; Bengt Glimelius; Henrik Hjalgrim; Mads Melbye; Paolo Crosignani; Simonetta di Lollo; Lucia Miligi; Oriana Nanni; Valerio Ramazzotti; Stefania Rodella; Adele Seniori Costantini; Emanuele Stagnaro; Rosario Tumino; Carla Vindigni; Paolo Vineis; Nikolaus Becker; Yolanda Benavente; Paolo Boffetta; Paul Brennan; Pierluigi Cocco; Lenka Foretova; Marc Maynadié; Alexandra Nieters; Anthony Staines; Joanne S Colt; Wendy Cozen; Scott Davis; Anneclaire J de Roos; Patricia Hartge; Nathaniel Rothman; Richard K Severson; Elizabeth A Holly; Timothy G Call; Andrew L Feldman; Thomas M Habermann; Mark Liebow; Aaron Blair; Kenneth P Cantor; Eleanor V Kane; Tracy Lightfoot; Eve Roman; Alex Smith; Angela Brooks-Wilson; Joseph M Connors; Randy D Gascoyne; John J Spinelli; Bruce K Armstrong; Anne Kricker; Theodore R Holford; Qing Lan; Tongzhang Zheng; Laurent Orsi; Luigino Dal Maso; Silvia Franceschi; Carlo La Vecchia; Eva Negri; Diego Serraino; Leslie Bernstein; Alexandra Levine; Jonathan W Friedberg; Jennifer L Kelly; Sonja I Berndt; Brenda M Birmann; Christina A Clarke; Christopher R Flowers; James M Foran; Marshall E Kadin; Ora Paltiel; Dennis D Weisenburger; Martha S Linet; Joshua N Sampson
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08
View more
  10 in total

1.  A note of thanks and an invitation.

Authors:  Albert Hofman
Journal:  Eur J Epidemiol       Date:  2018-12       Impact factor: 8.082

Review 2.  Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Authors:  Tsuyoshi Hamada; Jonathan A Nowak; Danny A Milner; Mingyang Song; Shuji Ogino
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

Review 3.  Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.

Authors:  Shuji Ogino; Jonathan A Nowak; Tsuyoshi Hamada; Amanda I Phipps; Ulrike Peters; Danny A Milner; Edward L Giovannucci; Reiko Nishihara; Marios Giannakis; Wendy S Garrett; Mingyang Song
Journal:  Gut       Date:  2018-02-06       Impact factor: 23.059

Review 4.  Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology.

Authors:  Shuji Ogino; Jonathan A Nowak; Tsuyoshi Hamada; Danny A Milner; Reiko Nishihara
Journal:  Annu Rev Pathol       Date:  2018-08-20       Impact factor: 23.472

5.  Utility of inverse probability weighting in molecular pathological epidemiology.

Authors:  Li Liu; Daniel Nevo; Reiko Nishihara; Yin Cao; Mingyang Song; Tyler S Twombly; Andrew T Chan; Edward L Giovannucci; Tyler J VanderWeele; Molin Wang; Shuji Ogino
Journal:  Eur J Epidemiol       Date:  2017-12-20       Impact factor: 8.082

6.  A latent unknown clustering integrating multi-omics data (LUCID) with phenotypic traits.

Authors:  Cheng Peng; Jun Wang; Isaac Asante; Stan Louie; Ran Jin; Lida Chatzi; Graham Casey; Duncan C Thomas; David V Conti
Journal:  Bioinformatics       Date:  2020-02-01       Impact factor: 6.937

7.  Attributing diseases to multiple pathways: a causal-pie modeling approach.

Authors:  Christine Chen; Wen-Chung Lee
Journal:  Clin Epidemiol       Date:  2018-04-27       Impact factor: 4.790

8.  Utility of Continuous Disease Subtyping Systems for Improved Evaluation of Etiologic Heterogeneity.

Authors:  Ruitong Li; Tomotaka Ugai; Lantian Xu; David Zucker; Shuji Ogino; Molin Wang
Journal:  Cancers (Basel)       Date:  2022-04-02       Impact factor: 6.639

9.  Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology.

Authors:  Shuji Ogino; Iny Jhun; Douglas A Mata; Thing Rinda Soong; Tsuyoshi Hamada; Li Liu; Reiko Nishihara; Marios Giannakis; Yin Cao; JoAnn E Manson; Jonathan A Nowak; Andrew T Chan
Journal:  NPJ Precis Oncol       Date:  2017-12-06

10.  One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status.

Authors:  Robin Myte; Björn Gylling; Jenny Häggström; Jörn Schneede; Anna Löfgren-Burström; Jeroen R Huyghe; Göran Hallmans; Klaus Meyer; Ingegerd Johansson; Per Magne Ueland; Richard Palmqvist; Bethany Van Guelpen
Journal:  PLoS One       Date:  2018-04-25       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.